Kenvue Inc. $KVUE Shares Bought by Burgundy Asset Management Ltd.

Burgundy Asset Management Ltd. grew its position in shares of Kenvue Inc. (NYSE:KVUE) by 9.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,148,796 shares of the company’s stock after purchasing an additional 592,854 shares during the period. Burgundy Asset Management Ltd. owned approximately 0.37% of Kenvue worth $149,624,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in KVUE. Norges Bank acquired a new stake in shares of Kenvue during the second quarter valued at about $537,418,000. Independent Franchise Partners LLP raised its holdings in Kenvue by 233.4% in the second quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock valued at $654,388,000 after acquiring an additional 21,886,537 shares in the last quarter. Third Point LLC bought a new position in Kenvue during the 1st quarter valued at $213,422,000. Maverick Capital Ltd. acquired a new position in Kenvue during the 1st quarter worth $203,036,000. Finally, American Century Companies Inc. increased its position in shares of Kenvue by 38.6% in the 2nd quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock worth $633,447,000 after purchasing an additional 8,436,166 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on KVUE shares. Edward Jones cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Jefferies Financial Group cut their price objective on Kenvue from $25.00 to $23.00 and set a “buy” rating on the stock in a research note on Monday, October 27th. Canaccord Genuity Group reaffirmed a “hold” rating and set a $15.00 target price (down previously from $26.00) on shares of Kenvue in a report on Wednesday, October 29th. Rothschild Redb upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Finally, Evercore ISI set a $18.00 price target on Kenvue in a research report on Tuesday, October 28th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and thirteen have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $20.23.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $16.92 on Friday. The stock has a market cap of $32.42 billion, a price-to-earnings ratio of 22.56 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The stock’s 50 day moving average price is $16.09 and its 200 day moving average price is $19.32.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The firm had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. During the same period last year, the company posted $0.28 EPS. The firm’s quarterly revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were given a $0.2075 dividend. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 annualized dividend and a yield of 4.9%. Kenvue’s payout ratio is 110.67%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.